Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
ILM1.DE
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.22
+189%
0.11
vs -0.12
Q1.23
-3%
0.2
vs 0.21
Q2.23
-11%
0.19
vs 0.21
Q3.23
+19%
0.3
vs 0.25
Q4.23
-7%
0.1
vs 0.11
Q1.24
-17%
0.17
vs 0.2
Q2.24
-47%
0.1
vs 0.19
Q3.24
-15%
0.25
vs 0.3
Q4.24
-19%
0.08
vs 0.1
Q1.25
+49%
0.25
vs 0.17
Sales Growth
YoY
Current
Estimates
Q4.22
+8%
399.4M vs 368.6M
Q1.23
+10%
431.2M vs 393M
Q2.23
+6%
422.3M vs 399.2M
Q3.23
+17%
489.9M vs 419.2M
Q4.23
+10%
441.2M vs 399.4M
Q1.24
+6%
456.2M vs 431.2M
Q2.24
+7%
451M vs 422.3M
Q3.24
+1%
493.2M vs 489.9M
Q4.24
+9%
482.5M vs 441.2M
Q1.25
+6%
484.7M vs 456.2M
Return on Equity
QoQ
Q2.23
+1%
0.01
vs 0.01
Q3.23
+2%
0.02
vs 0.01
Q4.23
+1%
0.01
vs 0.02
Q1.24
+1%
0.01
vs 0.01
Q2.24
+0%
0
vs 0.01
Q3.24
+1%
0.01
vs 0
Q4.24
+0%
0
vs 0.01
Q1.25
+1%
0.01
vs 0
Institutionnal Ownership
Quote Panel
Key Metrics
Forecast
324%2026-Revenue
427%2026-EPS
166%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.
XETRA
-0.28Â ( -2.19%)
Relative Strenght
Volume Buzz
101%
Earning Acce
No
Dist 52w H.
33%Relative Strength
ILM1.DE
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How ILM1.DE compares to sector?